Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
07/28/2023 | 22.04% | TD Cowen | $56 → $65 | Maintains | Outperform |
07/12/2023 | — | Jefferies | Upgrades | Underperform → Hold | |
06/13/2023 | 1.39% | Susquehanna | → $54 | Reiterates | Positive → Positive |
04/25/2023 | 1.39% | Susquehanna | $55 → $54 | Maintains | Positive |
01/27/2023 | 5.14% | Cowen & Co. | $50 → $56 | Maintains | Outperform |
01/27/2023 | 3.27% | Susquehanna | $50 → $55 | Maintains | Positive |
01/26/2023 | 3.27% | Craig-Hallum | $50 → $55 | Maintains | Buy |
01/11/2023 | — | Goldman Sachs | Downgrades | Neutral → Sell | |
12/12/2022 | -6.12% | Susquehanna | → $50 | Initiates Coverage On | → Positive |
11/08/2022 | — | Morgan Stanley | Initiates Coverage On | → Equal-Weight | |
10/17/2022 | — | William Blair | Initiates Coverage On | → Market Perform | |
04/12/2022 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
01/28/2022 | 16.41% | Baird | $50 → $62 | Upgrades | Neutral → Outperform |
12/08/2021 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
07/22/2021 | — | Goldman Sachs | Upgrades | Sell → Neutral | |
04/30/2021 | -4.24% | Canaccord Genuity | $47 → $51 | Maintains | Buy |
02/18/2021 | — | Berenberg | Upgrades | Sell → Hold | |
01/13/2021 | — | UBS | Downgrades | Buy → Neutral | |
10/23/2020 | -11.75% | Canaccord Genuity | $36 → $47 | Maintains | Buy |
07/24/2020 | -32.41% | Canaccord Genuity | $32 → $36 | Maintains | Buy |
04/23/2020 | -39.92% | Canaccord Genuity | $41 → $32 | Maintains | Buy |
03/19/2020 | — | Citigroup | Upgrades | Neutral → Buy | |
01/24/2020 | -43.67% | Baird | $20 → $30 | Upgrades | Underperform → Neutral |
01/23/2020 | -36.16% | Craig-Hallum | $28 → $34 | Maintains | Buy |
01/08/2020 | — | Goldman Sachs | Downgrades | Buy → Neutral | |
01/06/2020 | -43.67% | Jefferies | → $30 | Initiates Coverage On | → Hold |
12/18/2019 | -24.9% | Canaccord Genuity | → $40 | Initiates Coverage On | → Buy |
08/09/2019 | -63.95% | Goldman Sachs | $18.6 → $19.2 | Upgrades | Neutral → Buy |
06/19/2019 | — | Morgan Stanley | Initiates Coverage On | → Overweight | |
05/31/2019 | — | B of A Securities | Upgrades | Neutral → Buy | |
02/22/2019 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
10/25/2018 | — | Baird | Downgrades | Outperform → Underperform | |
09/26/2018 | — | Deutsche Bank | Downgrades | Buy → Hold |
What is the target price for STMicroelectronics (STM)?
The latest price target for STMicroelectronics (NYSE: STM) was reported by TD Cowen on July 28, 2023. The analyst firm set a price target for $65.00 expecting STM to rise to within 12 months (a possible 22.04% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for STMicroelectronics (STM)?
The latest analyst rating for STMicroelectronics (NYSE: STM) was provided by TD Cowen, and STMicroelectronics maintained their outperform rating.
When is the next analyst rating going to be posted or updated for STMicroelectronics (STM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of STMicroelectronics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for STMicroelectronics was filed on July 28, 2023 so you should expect the next rating to be made available sometime around July 28, 2024.
Is the Analyst Rating STMicroelectronics (STM) correct?
While ratings are subjective and will change, the latest STMicroelectronics (STM) rating was a maintained with a price target of $56.00 to $65.00. The current price STMicroelectronics (STM) is trading at is $53.26, which is out of the analyst's predicted range.